1 ml of flowcomp release buffer Search Results


dynabeads flowcomp mouse pan t cd90 2 kit  (Fisher Scientific)
86
Fisher Scientific dynabeads flowcomp mouse pan t cd90 2 kit
Dynabeads Flowcomp Mouse Pan T Cd90 2 Kit, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1+ml+of+flowcomp+release+buffer/bio_rxiv__64898__2026__03__04__709614-387-29-36?v=Fisher+Scientific
Average 86 stars, based on 1 article reviews
dynabeads flowcomp mouse pan t cd90 2 kit - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
cartesian tfe with both flow compensation and complex-conjugate reconstruction  (HighRes Biosolutions)
90
HighRes Biosolutions cartesian tfe with both flow compensation and complex-conjugate reconstruction
Cartesian Tfe With Both Flow Compensation And Complex Conjugate Reconstruction, supplied by HighRes Biosolutions, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1+ml+of+flowcomp+release+buffer/pm16865385-72-15-17?v=HighRes+Biosolutions
Average 90 stars, based on 1 article reviews
cartesian tfe with both flow compensation and complex-conjugate reconstruction - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
dynabeads flowcomp  (Thermo Fisher)
96
Thermo Fisher dynabeads flowcomp
Dynabeads Flowcomp, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1+ml+of+flowcomp+release+buffer/pmc04490118-88-0-2?v=Thermo+Fisher
Average 96 stars, based on 1 article reviews
dynabeads flowcomp - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
dynabeads  (Thermo Fisher)
99
Thermo Fisher dynabeads
Dynabeads, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1+ml+of+flowcomp+release+buffer/pmc04947829-57-25-29?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
dynabeads - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
flowcomp dynabeads  (Thermo Fisher)
99
Thermo Fisher flowcomp dynabeads
Flowcomp Dynabeads, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1+ml+of+flowcomp+release+buffer/ppr0561294-57-6-8?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
flowcomp dynabeads - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
dynabeads flowcomp mouse cd4 cd25 treg cells kit  (Thermo Fisher)
97
Thermo Fisher dynabeads flowcomp mouse cd4 cd25 treg cells kit
Changes in percentages of <t>CD4+CD25+</t> lymphocytes and FOXP3 expression levels. (a) Lymphocytes were harvested at the indicated time points and dual-stained with CD25 and CD4 mAbs. The percentages of Tregs in the total lymphocytes on different days are shown. Non-specific antibody labeling was determined using isotype-matched negative control antibodies. (b) The ratio of <t>Treg/CD4+</t> cells from Figure 2a is shown as a bar graph. The difference between the BALB/c and tumor groups was significant (P=0.003). The ratio of Treg/CD4+ cells in the tumor and CY8 groups was significantly different (the tumor group vs. the CY8 group, P=0.0004), and levels in the CY14 group slightly exceeded those in the tumor group (tumor group vs. CY14 group, P=0.4056). (c) Equivalent numbers of the lymphocytes at the indicated time points were harvested, and total RNA was extracted for real-time PCR. All data are representative of three independent experiments and expressed as the mean±s.d. The FOXP3 mRNA expression of specified groups significantly differed (tumor group vs. BALB/c group, *P=0.0164; CY8 group vs. tumor group, ***P<0.001). (d, e) Equivalent numbers of lymphocytes were harvested at the indicated time points with or without A20 cells and CY, and total protein was extracted for western blot analyses. d shows the intensity of the FOXP3 band normalized to the β-actin band. e shows the CY treatment transiently reduced the protein expression of FOXP3. The changes in protein levels were consistent with the mRNA changes that are shown in c. CY, cyclophosphamide; mAb, monoclonal antibody; PCR, polymerase chain reaction; Treg, regulatory T cell.
Dynabeads Flowcomp Mouse Cd4 Cd25 Treg Cells Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1+ml+of+flowcomp+release+buffer/pmc04002215-50-1-14?v=Thermo+Fisher
Average 97 stars, based on 1 article reviews
dynabeads flowcomp mouse cd4 cd25 treg cells kit - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier

Image Search Results


Changes in percentages of CD4+CD25+ lymphocytes and FOXP3 expression levels. (a) Lymphocytes were harvested at the indicated time points and dual-stained with CD25 and CD4 mAbs. The percentages of Tregs in the total lymphocytes on different days are shown. Non-specific antibody labeling was determined using isotype-matched negative control antibodies. (b) The ratio of Treg/CD4+ cells from Figure 2a is shown as a bar graph. The difference between the BALB/c and tumor groups was significant (P=0.003). The ratio of Treg/CD4+ cells in the tumor and CY8 groups was significantly different (the tumor group vs. the CY8 group, P=0.0004), and levels in the CY14 group slightly exceeded those in the tumor group (tumor group vs. CY14 group, P=0.4056). (c) Equivalent numbers of the lymphocytes at the indicated time points were harvested, and total RNA was extracted for real-time PCR. All data are representative of three independent experiments and expressed as the mean±s.d. The FOXP3 mRNA expression of specified groups significantly differed (tumor group vs. BALB/c group, *P=0.0164; CY8 group vs. tumor group, ***P<0.001). (d, e) Equivalent numbers of lymphocytes were harvested at the indicated time points with or without A20 cells and CY, and total protein was extracted for western blot analyses. d shows the intensity of the FOXP3 band normalized to the β-actin band. e shows the CY treatment transiently reduced the protein expression of FOXP3. The changes in protein levels were consistent with the mRNA changes that are shown in c. CY, cyclophosphamide; mAb, monoclonal antibody; PCR, polymerase chain reaction; Treg, regulatory T cell.

Journal: Cellular and Molecular Immunology

Article Title: Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma model

doi: 10.1038/cmi.2012.34

Figure Lengend Snippet: Changes in percentages of CD4+CD25+ lymphocytes and FOXP3 expression levels. (a) Lymphocytes were harvested at the indicated time points and dual-stained with CD25 and CD4 mAbs. The percentages of Tregs in the total lymphocytes on different days are shown. Non-specific antibody labeling was determined using isotype-matched negative control antibodies. (b) The ratio of Treg/CD4+ cells from Figure 2a is shown as a bar graph. The difference between the BALB/c and tumor groups was significant (P=0.003). The ratio of Treg/CD4+ cells in the tumor and CY8 groups was significantly different (the tumor group vs. the CY8 group, P=0.0004), and levels in the CY14 group slightly exceeded those in the tumor group (tumor group vs. CY14 group, P=0.4056). (c) Equivalent numbers of the lymphocytes at the indicated time points were harvested, and total RNA was extracted for real-time PCR. All data are representative of three independent experiments and expressed as the mean±s.d. The FOXP3 mRNA expression of specified groups significantly differed (tumor group vs. BALB/c group, *P=0.0164; CY8 group vs. tumor group, ***P<0.001). (d, e) Equivalent numbers of lymphocytes were harvested at the indicated time points with or without A20 cells and CY, and total protein was extracted for western blot analyses. d shows the intensity of the FOXP3 band normalized to the β-actin band. e shows the CY treatment transiently reduced the protein expression of FOXP3. The changes in protein levels were consistent with the mRNA changes that are shown in c. CY, cyclophosphamide; mAb, monoclonal antibody; PCR, polymerase chain reaction; Treg, regulatory T cell.

Article Snippet: A Dynabeads FlowComp Mouse CD4 + CD25 + Treg Cells Kit was obtained from Invitrogen (Carlsbad, CA, USA).

Techniques: Expressing, Staining, Antibody Labeling, Negative Control, Real-time Polymerase Chain Reaction, Western Blot, Polymerase Chain Reaction